These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 31464058)
21. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes. Dobson L; Stride A; Bingham C; Elworthy S; Sheldon CD; Hattersley AT Pediatr Pulmonol; 2005 Feb; 39(2):103-7. PubMed ID: 15573388 [TBL] [Abstract][Full Text] [Related]
22. Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure. Hull RL; Gibson RL; McNamara S; Deutsch GH; Fligner CL; Frevert CW; Ramsey BW; Sanda S Diabetes Care; 2018 Apr; 41(4):823-830. PubMed ID: 29437698 [TBL] [Abstract][Full Text] [Related]
23. Why is insulin pump treatment rarely used in adolescents and young adults with cystic fibrosis-related diabetes? Scheuing N; Badenhoop K; Borkenstein M; Konrad K; Lilienthal E; Laubner K; Naeke A; Rami-Merhar B; Thon A; Wiemann D; Holl RW; Pediatr Diabetes; 2015 Feb; 16(1):10-5. PubMed ID: 24984902 [TBL] [Abstract][Full Text] [Related]
24. Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus. Moura Neto A; Parisi MC; Alegre SM; Pavin EJ; Tambascia MA; Zantut-Wittmann DE Endocrine; 2016 Jan; 51(1):63-71. PubMed ID: 26049370 [TBL] [Abstract][Full Text] [Related]
25. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus. Noronha RM; Damaceno N; Muramatu LH; Monte O; Calliari LE Pediatr Diabetes; 2014 Jun; 15(4):309-12. PubMed ID: 24256553 [TBL] [Abstract][Full Text] [Related]
26. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes. Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873 [TBL] [Abstract][Full Text] [Related]
27. Cardiac Autonomic Neuropathy Is Not Reversed by Euglycemia Following Islet Transplantation. Deshmukh T; Emerson P; Anderson P; Kizana E; O'Connell PJ; Holmes-Walker DJ; Chong JJH Transplantation; 2021 May; 105(5):1125-1129. PubMed ID: 32590611 [TBL] [Abstract][Full Text] [Related]
28. High-sensitivity C-reactive protein, low-grade systemic inflammation and type 2 diabetes mellitus: A two-sample Mendelian randomization study. Noordam R; Oudt CH; Bos MM; Smit RAJ; van Heemst D Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):795-802. PubMed ID: 29753585 [TBL] [Abstract][Full Text] [Related]
29. Significant retinopathy in young-onset type 2 vs. type 1 diabetes: a clinical observation. Song SH Int J Clin Pract; 2016 Oct; 70(10):853-860. PubMed ID: 27028787 [TBL] [Abstract][Full Text] [Related]
30. Dietary quality and markers of inflammation: No association in youth with type 1 diabetes. Liese AD; Ma X; Ma X; Mittleman MA; The NS; Standiford DA; Lawrence JM; Pihoker C; Marcovina SM; Mayer-Davis EJ; Puett RC J Diabetes Complications; 2018 Feb; 32(2):179-184. PubMed ID: 29198994 [TBL] [Abstract][Full Text] [Related]
31. Soluble endothelial protein C receptor and high sensitivity C reactive protein levels as markers of endothelial dysfunction in patients with type 1 and type 2 diabetes mellitus: their role in the prediction of vascular complications. Zaghloul A; Al-Bukhari TA; Al-Pakistani HA; Shalaby M; Halawani SH; Bajuaifer N; Teama SH Diabetes Res Clin Pract; 2014 Dec; 106(3):597-604. PubMed ID: 25312870 [TBL] [Abstract][Full Text] [Related]
32. Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Mousa A; Naderpoor N; Teede H; Scragg R; de Courten B Nutr Rev; 2018 May; 76(5):380-394. PubMed ID: 29490085 [TBL] [Abstract][Full Text] [Related]
33. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Lopes-Virella MF; Baker NL; Hunt KJ; Cleary PA; Klein R; Virella G; Diabetes Care; 2013 Aug; 36(8):2317-23. PubMed ID: 23514730 [TBL] [Abstract][Full Text] [Related]
34. Role of circulating inflammatory protein in the development of diabetic renal complications: proteome-wide Mendelian randomization and colocalization analyses. Liu W; Zhang J; Zhang D; Zhang L Front Endocrinol (Lausanne); 2024; 15():1406442. PubMed ID: 39040677 [TBL] [Abstract][Full Text] [Related]
35. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis. Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051 [TBL] [Abstract][Full Text] [Related]
36. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report. Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073 [TBL] [Abstract][Full Text] [Related]
37. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus. Gomes MB; Cobas RA; Nunes E; Castro-Faria-Neto HC; da Matta MF; Neves R; Tibiriçá E Diabetes Res Clin Pract; 2009 Jul; 85(1):61-8. PubMed ID: 19464746 [TBL] [Abstract][Full Text] [Related]
38. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D). Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334 [TBL] [Abstract][Full Text] [Related]
39. Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates. Aburawi EH; AlKaabi J; Zoubeidi T; Shehab A; Lessan N; Al Essa A; Yasin J; Saadi H; Souid AK PLoS One; 2016; 11(7):e0159808. PubMed ID: 27459718 [TBL] [Abstract][Full Text] [Related]
40. Elevated serum milk fat globule-epidermal growth factor 8 levels in type 2 diabetic patients are suppressed by overweight or obese status. Li Y; Ran W; Zhang J; Chen S; Li Y; Luo D; Wang C; Jia W IUBMB Life; 2017 Feb; 69(2):63-71. PubMed ID: 28067023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]